Edition:
United Kingdom

Aspen Pharmacare Holdings Ltd (APNJ.J)

APNJ.J on Johannesburg Stock Exchange

13,220.00ZAc
12:05pm GMT
Change (% chg)

-238.00 (-1.77%)
Prev Close
13,458.00
Open
13,458.00
Day's High
13,672.00
Day's Low
13,145.00
Volume
610,764
Avg. Vol
2,196,071
52-wk High
29,800.00
52-wk Low
12,818.00

Chart for

About

Aspen Pharmacare Holdings Limited is a South Africa-based supplier and manufacturer of branded and generic pharmaceutical products, as well as infant nutritional and consumer healthcare products. The Company's segments include International, South Africa, Asia Pacific and Sub-Saharan Africa (SSA). Its International business... (more)

Overall

Beta: 0.56
Market Cap(Mil.): R139,674.20
Shares Outstanding(Mil.): 456.45
Dividend: 287.00
Yield (%): 0.94

Financials

  APNJ.J Industry Sector
P/E (TTM): 27.38 31.13 34.40
EPS (TTM): 11.17 -- --
ROI: 6.19 15.55 14.96
ROE: 11.92 16.92 16.53

UPDATE 1-Aspen Pharmacare drops on debt worries and revenue forecast

JOHANNESBURG, Dec 14 Shares in Aspen Pharmacare fell more than 8 percent on Friday, a day after the South African drugmaker said it had negotiated a temporary relaxation of its lending agreements and forecast little growth in full-year revenues.

14 Dec 2018

South Africa's Aspen strikes distribution deal with U.S. drugmaker Mylan

JOHANNESBURG Aspen Pharmacare has struck a deal with U.S. generics maker Mylan to distribute a portfolio of prescription and over-the-counter drugs in Australia and New Zealand.

13 Dec 2018

UPDATE 1-South Africa's Aspen strikes distribution deal with U.S. drugmaker Mylan

JOHANNESBURG, Dec 13 Aspen Pharmacare has struck a deal with U.S. generics maker Mylan to distribute a portfolio of prescription and over-the-counter drugs in Australia and New Zealand.

13 Dec 2018

South Africa's Aspen launches three-in-one HIV drug

JOHANNESBURG South African drugmaker Aspen Pharmacare on Monday launched a triple-combination tablet for the treatment of HIV in the country where the virus is most prevalent.

26 Nov 2018

South Africa's Aspen launches three-in-one HIV drug

JOHANNESBURG, Nov 26 South African drugmaker Aspen Pharmacare on Monday launched a triple-combination tablet for the treatment of HIV in the country where the virus is most prevalent.

26 Nov 2018

Kraft to sell Canada natural cheese business to Parmalat

Kraft Heinz Co has agreed to sell its Canadian natural cheese business to Parmalat SpA in a C$1.62 billion ($1.23 billion) deal that will help Kraft trim its debt and extend the North American footprint of Parmalat owner Lactalis.

07 Nov 2018

Kraft to sell Canada natural cheese business to Parmalat

Kraft Heinz Co has agreed to sell its Canadian natural cheese business to Parmalat SpA in a C$1.62 billion (941.28 million pounds) deal that will help Kraft trim its debt and extend the North American footprint of Parmalat owner Lactalis.

07 Nov 2018

UPDATE 3-Kraft to sell Canada natural cheese business to Parmalat

* Parmalat and owner Lactalis reinforce N. America presence (Adds background and statement from Parmalat owner Lactalis)

07 Nov 2018

South Africa’s Aspen to invest $231 million in sterile anaesthetics manufacturing

JOHANNESBURG, Oct 26 South African drug maker Aspen Pharmacare will invest an additional 3.4 billion rand ($231 million) at its Port Elizabeth plant, it said on Friday at an investment summit in Johannesburg.

26 Oct 2018

Aspen Pharma suffers week of woe as valuation tumbles by $3 bln

* Investors spooked by debt levels and sale of baby milk business

21 Sep 2018

Earnings vs. Estimates